Results 251 to 260 of about 629,825 (307)

Aptamer‐Engineered Liposomal Platform Enables in Situ cDC1 Vaccination to Potentiate Immunotherapy in Prostate Cancer

open access: yesAdvanced Science, EarlyView.
Prostate cancer is immunologically ‘cold’, with scarce, dysfunctional type 1 conventional dendritic cells (cDC1s) that limit T cell priming. We introduce an aptamer‐targeted liposomedelivering FMS‐like tyrosine kinase 3 ligand (Flt3L) and chlorin e6 (Ce6). Ultrasound induces antigen release and cDC1s recruitment, creating an in situ cDC1 vaccine.
Jiayi Wang   +8 more
wiley   +1 more source

High baseline PD-1+ CD8 T Cells and TIGIT+ CD8 T Cells in circulation associated with response to PD-1 blockade in patients with non-small cell lung cancer. [PDF]

open access: yesCancer Immunol Immunother
Dutta N   +11 more
europepmc   +1 more source

Brain-infiltrating CD8 T cells retain functional activity to protect against acute Zika virus infection. [PDF]

open access: yesSci Rep
Kim J   +9 more
europepmc   +1 more source

CD4+ and CD8+ T cells are not the main driver of Lassa fever pathogenesis in macaques. [PDF]

open access: yesJCI Insight
Prévost J   +13 more
europepmc   +1 more source

XCR1+ and CD11b+ migratory dendritic cells cooperate for the cross-priming of intratumoral CD8+ T cells with a tissue-resident memory phenotype.

open access: yes
Guermonprez P   +35 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy